安徽丰原药业股份有限公司

The company is a listed company in the pharmaceutical sector. It is the first listed pharmaceutical company in Anhui Province. It integrates pharmaceutical R&D, production and sales. It is a high-tech enterprise, a nationally recognized enterprise technology center, and one of the top 100 enterprises in China's pharmaceutical industry. The company's main business includes pharmaceutical manufacturing and commercial distribution. Among them, pharmaceutical manufacturing involves R&D, production and sales of biopharmaceuticals, chemicals and traditional Chinese medicines. The company's main products include fructose series, fatty milk series, drug-loaded fatty milk series, amino acid series, ambroxol glucose injection, isosorbide mononitrate injection, levofloxacin lactate injection, lysaprine series, injectable alanaminorelin acetate, coenzyme A, injectable dexamethasone phosphate, injectable bromhexine hydrochloride, injectable lansoprazole sodium hydrochloride, compound atticaine hydrochloride injection, and ifrib fumarate injections Solution, oxytocin injection, lysampirine powder, cinedipine tablets, napidipine tablets, zaleplon tablets, aminophenol pseudosamine Clotine tablets, lactozenin capsules, prolactin granules, diclofenac tablets, lysapirine raw materials, fructose ingredients, paracetamol ingredients, adrenaline ingredients, etc. The company's honors include high-tech product certification, 2015 China's innovative pharmaceutical enterprise, 2014 China's top 100 pharmaceutical industry, high-tech enterprise, national certified enterprise technology center, China's top 100 pharmaceutical industry enterprises, top 100 pharmaceutical manufacturing enterprises, “three product” demonstration enterprises in the consumer goods industry in Anhui Province, and industrial quality in Anhui Province.